HFA-PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation

Aims Many transcatheter aortic valve implantation (TAVI) candidates have underlying heart failure with preserved ejection fraction (HFpEF) in addition to symptomatic aortic stenosis. Diagnosis of HFpEF is challenging. The Heart Failure Association of the European Society of Cardiology proposed the H...

Full description

Saved in:
Bibliographic Details
Main Authors: Seoudy, Hatim (Author) , Eberstein, Mira von (Author) , Frank, Johanne (Author) , Thomann, Maren (Author) , Pühler, Thomas (Author) , Lutter, Georg (Author) , Lutz, Matthias (Author) , Bramlage, Peter (Author) , Frey, Norbert (Author) , Saad, Mohammed (Author) , Frank, Derk (Author)
Format: Article (Journal)
Language:English
Published: April 2022
In: ESC heart failure
Year: 2022, Volume: 9, Issue: 2, Pages: 1071-1079
ISSN:2055-5822
DOI:10.1002/ehf2.13774
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1002/ehf2.13774
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13774
Get full text
Author Notes:Hatim Seoudy, Mira von Eberstein, Johanne Frank, Maren Thomann, Thomas Puehler, Georg Lutter, Matthias Lutz, Peter Bramlage, Norbert Frey, Mohammed Saad and Derk Frank
Description
Summary:Aims Many transcatheter aortic valve implantation (TAVI) candidates have underlying heart failure with preserved ejection fraction (HFpEF) in addition to symptomatic aortic stenosis. Diagnosis of HFpEF is challenging. The Heart Failure Association of the European Society of Cardiology proposed the HFA-PEFF score as part of a novel diagnostic algorithm. This study assessed the prognostic value of the HFA-PEFF score in patients with preserved ejection fraction after TAVI. Methods and results This single-centre study included 570 consecutive TAVI patients with a preserved left ventricular ejection fraction of ≥50%. Patients with an HFA-PEFF score of ≥5 [n = 239 (41.9%)] were compared with those with <5 points [n = 331 (58.1%)]. The primary outcome was a composite of all-cause mortality or first heart failure rehospitalization within 1 year after TAVI. Secondary endpoints were the individual components of the primary outcome. Patients with an HFA-PEFF score ≥ 5 had higher rates of comorbidities commonly associated with HFpEF, a higher rate of new pacemaker implantation after TAVI, were at increased risk of the primary composite endpoint (25.5% vs. 10.0%, P < 0.001), and rehospitalization for heart failure (11.7% vs. 3.9%, P < 0.001). Multivariable analysis confirmed an HFA-PEFF score ≥ 5 as an independent risk factor for the composite endpoint [hazard ratio 2.70, 95% confidence interval (CI) 1.70-4.28, P < 0.001] and for all-cause mortality (hazard ratio 2.58, 95% CI 1.46-4.53, P = 0.001). Conclusion The HFA-PEFF score is associated with all-cause mortality and heart failure rehospitalization in patients with preserved ejection fraction after TAVI. This practical tool can easily be incorporated into risk stratification algorithms for TAVI patients.
Item Description:Online veröffentlicht: 29. Januar 2022
Gesehen am 29.08.2024
Physical Description:Online Resource
ISSN:2055-5822
DOI:10.1002/ehf2.13774